Ken Yoshii

658 total citations · 1 hit paper
13 papers, 441 citations indexed

About

Ken Yoshii is a scholar working on Immunology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ken Yoshii has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 2 papers in Infectious Diseases and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ken Yoshii's work include Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Ken Yoshii is often cited by papers focused on Immune Response and Inflammation (6 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Ken Yoshii collaborates with scholars based in Japan, United States and Singapore. Ken Yoshii's co-authors include Koji Hosomi, Jun Kunisawa, Kento Sawane, Atsushi Shimoyama, Koichi Fukase, Takahiro Nagatake, Hiroshi Kiyono, Hiroshi Kiyono, Yukari Fujimoto and Azusa Saika and has published in prestigious journals such as Scientific Reports, Journal of Lipid Research and Frontiers in Immunology.

In The Last Decade

Ken Yoshii

12 papers receiving 435 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity

2019 376 citations Ken Yoshii, Koji Hosomi et al. Frontiers in Nutrition profile →

Peers

Countries citing papers authored by Ken Yoshii

Since Specialization

Citations

This map shows the geographic impact of Ken Yoshii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Yoshii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Yoshii more than expected).

Fields of papers citing papers by Ken Yoshii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Yoshii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Yoshii. The network helps show where Ken Yoshii may publish in the future.

Co-authorship network of co-authors of Ken Yoshii

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Yoshii. A scholar is included among the top collaborators of Ken Yoshii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Yoshii. Ken Yoshii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	17,18-epoxyeicosatetraenoic acid ameliorates mRNA-LNP–induced local inflammation by inhibiting neutrophil infiltration 2025 ·Journal of Lipid Research ·(unknown), Ken Yoshii, (unknown), (unknown), (unknown), Saki Kondo, Koichiro Ishida, Takahiro Nagatake, Jun Kunisawa	0
2	Establishment of enterotype-specific antibodies for various diagnostic systems 2025 ·Scientific Reports ·Ken Yoshii, Eri Node, Mari Furuta, Yoko Tojima, (unknown), Jun Adachi, (unknown), Makiko Morita, Koji Hosomi, Jun Kunisawa	1
3	QcrC is a potential target for antibody therapy and vaccination to control Campylobacter jejuni infection by suppressing its energy metabolism 2024 ·Frontiers in Microbiology ·Koji Hosomi, Noritoshi Hatanaka, Atsushi Hinenoya, Jun Adachi, Yoko Tojima, Mari Furuta, (unknown), Makiko Morita, Takahiro Nagatake, Azusa Saika, (unknown), Ken Yoshii, (unknown), Shinji Yamasaki, Jun Kunisawa	2
4	TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells 2023 ·International Immunopharmacology ·(unknown), Koji Hosomi, Atsushi Shimoyama, Ken Yoshii, (unknown), (unknown), (unknown), Takahiro Nagatake, Ken J. Ishii, Shizuo Akira, Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	6
5	Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue 2023 ·International Immunology ·(unknown), (unknown), Atsushi Shimoyama, Ken Yoshii, Azusa Saika, (unknown), Takahiro Nagatake, Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	2
6	Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria Alcaligenes faecalis Functions as an Effective Nasal Adjuvant to Augment IgA Antibody and Th17 Cell Responses 2021 ·Frontiers in Immunology ·(unknown), Koji Hosomi, Atsushi Shimoyama, Ken Yoshii, Takahiro Nagatake, Yukari Fujimoto, Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	11
7	Chemically Synthesized Alcaligenes Lipid A as an Adjuvant to Augment Immune Responses to Haemophilus Influenzae Type B Conjugate Vaccine 2021 ·Frontiers in Pharmacology ·(unknown), Koji Hosomi, Atsushi Shimoyama, Ken Yoshii, (unknown), (unknown), (unknown), (unknown), (unknown), Azusa Saika, Takahiro Nagatake, Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	4
8	Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus pneumoniae-Specific IgA and Th17 Mediated Protective Immunity 2020 ·Microorganisms ·Ken Yoshii, Koji Hosomi, Atsushi Shimoyama, (unknown), (unknown), Takahiro Nagatake, Hidehiko Suzuki, (unknown), Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	14
9	Adjuvant Activity of Synthetic Lipid A of Alcaligenes, a Gut-Associated Lymphoid Tissue-Resident Commensal Bacterium, to Augment Antigen-Specific IgG and Th17 Responses in Systemic Vaccine 2020 ·Vaccines ·(unknown), Koji Hosomi, Atsushi Shimoyama, Ken Yoshii, (unknown), Takahiro Nagatake, (unknown), Hiroshi Kiyono, Koichi Fukase, Jun Kunisawa	17
10	Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity breakdown → 2019 ·Frontiers in Nutrition ·Ken Yoshii, Koji Hosomi, Kento Sawane, Jun Kunisawa	376
11	Path lines in blood flow using high speed digital subtraction echography 2003 ·Ken Ishihara, Ken Yoshii, Kazuo Chihara, Kohji Masuda, (unknown), K. Shirae, Toshiyuki Furukawa	1
12	A cryocooled 61-channel MEG system 1997 ·Applied Superconductivity ·Tetsuo Yoshida, (unknown), Ken Yoshii, (unknown), Akifumi Suzuki	5
13	Quantitation of Fine Displacement in Echography 1993 ·Japanese Journal of Applied Physics ·Kohji Masuda, Ken Ishihara, Ken Yoshii, Toshiyuki Furukawa, (unknown), Hajime Maeda, Shinzo Kodama	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact